Aeglea Biotherapeutics Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Aeglea Biotherapeutics Inc
TickerSYRE
CIK #0001636282
CUSIP00773J202
SectorLife Sciences - Pharmaceutical Preparations
Address901 S Mopac Expressway, Ste 250 Barton Oaks Plaza One, Austin, TX 78746
Source [EDGAR]
CIK Filing 2011 - 2025
[0001636282] 10-K
[0001636282] 10-Q
[0001636282] 3
[0001636282] 4
[0001636282] 5
[0001636282] 8-K
[0001636282] D
[0001636282] SC 13D
[0001636282] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Vanguard Group Inc Spyre Therapeutics Inc [2025-07-29] 0.0
Tang Capital Management LLC Spyre Therapeutics Inc [2025-05-01] 0.0
BlackRock Inc Spyre Therapeutics Inc [2024-11-08] 5.2
Deutsch Peter E Spyre Therapeutics Inc [2024-10-23] 6.99
BlackRock Inc Spyre Therapeutics Inc [2024-10-22] 5.2
RTW Investments LP Spyre Therapeutics Inc [2024-02-14] 6.2
Avoro Capital Advisors LLC Spyre Therapeutics Inc [2024-02-14] 5.9
FMR LLC Spyre Therapeutics Inc [2024-02-09] 0.0
Perceptive Advisors LLC Spyre Therapeutics Inc [2023-12-13] 7.2
Commodore Capital LP Spyre Therapeutics Inc [2023-12-01] 6.1
Deutsch Peter E Aeglea Biotherapeutics Inc [2023-11-14] 0.48
Polar Capital Holdings PLC Aeglea Biotherapeutics Inc [2023-07-28] 5.02
Logos Global Management LP Aeglea Biotherapeutics Inc [2023-07-18] 8.1
Venrock Healthcare Capital Partners III LP Aeglea Biotherapeutics Inc [2023-07-10] 0.99
Affinity Asset Advisors LLC Aeglea Biotherapeutics Inc [2023-07-03] 0.23
EcoR1 Capital Fund Qualified LP Aeglea Biotherapeutics Inc [2023-06-30] 6.4
Fairmount Funds Management LLC Aeglea Biotherapeutics Inc [2023-06-30] 19.99
Deep Track Capital LP Aeglea Biotherapeutics Inc [2023-06-30] 0.99
Rock Springs Capital Management LP Aeglea Biotherapeutics Inc [2023-02-14] 5.55
Baker Bros Advisors LP Aeglea Biotherapeutics Inc [2023-02-14] 9.9
Pictet Asset Management Sa Aeglea Biotherapeutics Inc [2023-02-03] 0.0
Integrated Core Strategies US LLC Aeglea Biotherapeutics Inc [2022-12-01] 4.7
BlackRock Inc Aeglea Biotherapeutics Inc [2022-06-09] 4.8
Nantahala Capital Management LLC Aeglea Biotherapeutics Inc [2022-02-14] 5.7
Pictet Asset Management Sa Aeglea Biotherapeutics Inc [2022-02-10] 5.0
Suvretta Capital Management LLC Aeglea Biotherapeutics Inc [2021-12-16] 5.2
Baker Bros Advisors LP Aeglea Biotherapeutics Inc [2021-03-05] 0.9
Lilly Ventures Fund I LLC Aeglea Biotherapeutics Inc [2021-02-12] 5.4
Pictet Asset Management Sa Aeglea Biotherapeutics Inc [2021-02-10] 5.25
BlackRock Inc Aeglea Biotherapeutics Inc [2021-02-02] 6.8
Point72 Asset Management LP Aeglea Biotherapeutics Inc [2020-10-26] 6.2
BCLS II Equity Opportunities LP Aeglea Biotherapeutics Inc [2020-06-09] 6.1
BlackRock Inc Aeglea Biotherapeutics Inc [2019-02-08] 5.4
Adage Capital Partners GP LLC Aeglea Biotherapeutics Inc [2018-10-11] 6.61
Baker Bros Advisors LP Aeglea Biotherapeutics Inc [2018-02-13] 6.8
Nantahala Capital Management LLC Aeglea Biotherapeutics Inc [2017-12-08] 10.9
Lilly Ventures Fund I LLC Aeglea Biotherapeutics Inc [2017-02-14] 19.1
Prudential Financial Inc Aeglea Biotherapeutics Inc [2016-05-10] 10.7
Jennison Associates LLC Aeglea Biotherapeutics Inc [2016-05-09] 10.7
OrbiMed Advisors LLC Aeglea Biotherapeutics Inc [2016-04-18] 10.14
Novartis BioVentures Ltd Aeglea Biotherapeutics Inc [2016-04-14] 17.2
Form 3/4/5 Filer 2011 - 2025
Stelzer Laurie
Spyre Therapeutics, Inc.
Fairmount Funds Management LLC
Harwin Peter Evan
Kiselak Tomas
Fairmount Healthcare Fund II L.P.
Albers Jeffrey W.
Henderson Michael Thomas
McKenna Mark C.
Milligan Sandra
Sloan Sheldon
Burrows Scott L
King-Jones Heidy
Turtle Cameron
Fairmount Healthcare Co-Invest L.P.
Fairmount Healthcare Fund L.P.
Lawton Alison Frances
Alspaugh Jonathan
Cox Russell J.
Magovcevic-Liebisch Ivana
Smith Hunter C
Neuman Linda L
Kastenmayer James Paul
Hanley Jr. Michael Conick
Goldberg Jeff Marc
Souza Marcio
Sloan Leslie
Lawlis V Bryan
Mahatme Sandesh
Shanafelt Armen
Quinn Anthony G.
Weber Steven
Baker Bros Advisors LP
667 LP
Baker Felix
Baker Brothers Life Sciences LP
Baker Bros. Advisors (GP) LLC
Baker Julian
Brownstein Sara
Bruhn Suzanne Louise
York Charles N II
Rao Madduri Ravin
Wooldridge James
Schuchart Aaron
Georgiou George
Novartis Bioventures Ltd
Novartis AG
Rowlinson Scott W
Tyler Joseph E
Lowe David George
Hebel Henry
OrbiMed Capital GP V LLC
OrbiMed Advisors LLC
Isaly Samuel D
Rojas-Caro Sandra
ELI LILLY & Co
Torres S. Edward
Lilly Ventures Fund I LLC
Form 13F Holdings
Firm Period DFND Voting Shares
FMR LLC [2025-06-30] DFND 9,053,034 9,053,034
Fairmount Funds Management LLC [2025-06-30] SOLE 4,018,101 4,018,101
BlackRock, Inc. [2025-06-30] SOLE 3,905,236 4,007,296
RTW Investments LP [2025-06-30] SOLE 3,621,996 3,621,996
Tang Capital Management LLC [2025-06-30] OTR 0 3,200,000
Vanguard Group Inc [2025-06-30] SOLE 0 2,968,861
VR Adviser LLC [2025-06-30] SOLE 2,685,448 2,685,448
Braidwell LP [2025-06-30] SOLE 2,578,404 2,578,404
Capital International Investors [2025-06-30] DFND 2,392,541 2,392,541
Driehaus Capital Management LLC [2025-06-30] SOLE 1,783,088 2,085,590
Commodore Capital LP [2025-06-30] SOLE 1,988,084 1,988,084
Paradigm Biocapital Advisors LP [2025-06-30] SOLE 1,870,445 1,870,445
State Street Corp [2025-06-30] DFND 1,524,086 1,595,291
Perceptive Advisors LLC [2025-06-30] SOLE 1,529,445 1,529,445
Wellington Management Group LLP [2025-06-30] DFND 0 1,513,478
Jefferies Financial Group Inc. [2025-06-30] DFND 1,388,854 1,388,854
Geode Capital Management LLC [2025-06-30] DFND 1,227,232 1,227,232
Pictet Asset Management Holding SA [2025-06-30] SOLE 986,167 1,079,443
Franklin Resources Inc [2025-06-30] DFND 795,275 795,275
Polar Capital Holdings Plc [2025-06-30] DFND 745,000 745,000
Morgan Stanley [2025-06-30] DFND 660,716 671,044
Baker Bros Advisors LP [2025-06-30] SOLE 626,703 626,703
Deerfield Management Company LP [2025-06-30] DFND 613,665 613,665
Adage Capital Partners GP LLC [2025-06-30] SOLE 610,200 610,200
Affinity Asset Advisors LLC [2025-06-30] SOLE 606,678 606,678
Emerald Advisers LLC [2025-06-30] SOLE 430,675 565,863
Goldman Sachs Group Inc [2025-06-30] DFND 523,281 523,416
Blackstone Inc. [2025-06-30] OTR 0 489,248
Woodline Partners LP [2025-06-30] SOLE 465,152 465,152
UBS Group AG [2025-06-30] DFND 462,863 462,863
Prev | Page 1 | Next
Terms | Privacy | Guide
tony@aum13f.com